G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide

被引:30
作者
Meens, M. J. P. M. T.
Mattheij, N. J. A.
van Loenen, P. B. [2 ]
Spijkers, L. J. A. [2 ]
Lemkens, P.
Nelissen, J.
Compeer, M. G.
Alewijnse, A. E. [2 ]
De Mey, J. G. R. [1 ]
机构
[1] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol, NL-6200 MD Maastricht, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
关键词
CGRP receptor; vascular smooth muscle; G-proteins; endothelin; 7-transmembrane domain receptors; SMALL-MOLECULE DISRUPTION; SMOOTH-MUSCLE-CELLS; SELECTIVE INHIBITOR; ADENYLYL CYCLASES; BINDING-SITES; NITRIC-OXIDE; RECEPTOR; POTENT; CGRP; RAT;
D O I
10.1111/j.1476-5381.2011.01774.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND AND PURPOSE Calcitonin gene-related peptide (CGRP) has been proposed to relax vascular smooth muscle cells (VSMC) via cAMP and can promote dissociation of endothelin-1 (ET-1) from ETA receptors. The latter is not mimicked by other stimuli of adenylate cyclases. Therefore, we evaluated the involvement of G-protein beta? subunits (G beta?) in the arterial effects of CGRP receptor stimulation. EXPERIMENTAL APPROACH To test the hypothesis that instead of a subunits of G-proteins (Gas), Gbg mediates the effects of CGRP receptor activation, we used (i) rat isolated mesenteric resistance arteries (MRA), (ii) pharmacological modulators of cyclic nucleotides; and (iii) low molecular weight inhibitors of the functions of Gbg, gallein and M119. To validate these tools with respect to CGRP receptor function, we performed organ bath studies with rat isolated MRA, radioligand binding on membranes from CHO cells expressing human CGRP receptors and cAMP production assays in rat cultured VSMC. KEY RESULTS In isolated arteries contracted with K+ or ET-1, IBMX (PDE inhibitor) increased sodium nitroprusside (SNP)-and isoprenaline (ISO)-but not CGRP-induced relaxations. While fluorescein (negative control) was without effects, gallein increased binding of [ 125I]-CGRP in the absence and presence of GTPgS. Gallein also increased CGRP-induced cAMP production in VSMC. Despite these stimulating effects, gallein and M119 selectively inhibited the relaxing and anti-endothelinergic effects of CGRP in isolated arteries while not altering contractile responses to K+ or ET-1 or relaxing responses to ISO or SNP. CONCLUSION AND IMPLICATIONS Activated CGRP receptors induce cyclic nucleotide-independent relaxation of VSMC and terminate arterial effects of ET-1 via Gbg.
引用
收藏
页码:297 / 308
页数:12
相关论文
共 58 条
[21]   S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells [J].
Hendriks-Balk, Marielle C. ;
van Loenen, Pieter B. ;
Hajji, Najat ;
Michel, Martin C. ;
Peters, Stephan L. M. ;
Alewijnse, Astrid E. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 600 (1-3) :1-9
[22]   Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET [J].
Heroux, Madeleine ;
Breton, Billy ;
Hogue, Mireille ;
Bouvier, Michel .
BIOCHEMISTRY, 2007, 46 (23) :7022-7033
[23]   Myoendothelial coupling in the mesenteric arterial bed; segmental differences and interplay between nitric oxide and endothelin-1 [J].
Hilgers, R. H. P. ;
De Mey, J. G. R. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (08) :1239-1247
[24]   CGRP and its receptors provide new insights into migraine pathophysiology [J].
Ho, Tony W. ;
Edvinsson, Lars ;
Goadsby, Peter J. .
NATURE REVIEWS NEUROLOGY, 2010, 6 (10) :573-582
[25]  
Hynynen Meri M, 2006, Recent Pat Cardiovasc Drug Discov, V1, P95
[26]   K-252 COMPOUNDS, NOVEL AND POTENT INHIBITORS OF PROTEIN-KINASE-C AND CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES [J].
KASE, H ;
IWAHASHI, K ;
NAKANISHI, S ;
MATSUDA, Y ;
YAMADA, K ;
TAKAHASHI, M ;
MURAKATA, C ;
SATO, A ;
KANEKO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (02) :436-440
[27]   Endothelin Receptors and Pain [J].
Khodorova, Alla ;
Montmayeur, Jean-Pierre ;
Strichartz, Gary .
JOURNAL OF PAIN, 2009, 10 (01) :4-28
[28]   The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? [J].
Kirkby, N. S. ;
Hadoke, P. W. F. ;
Bagnall, A. J. ;
Webb, D. J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (06) :1105-1119
[29]   Small molecule disruption of G protein βγ subunit signaling inhibits neutrophil chemotaxis and inflammation [J].
Lehmann, D. M. ;
Seneviratne, A. M. P. B. ;
Smrcka, A. V. .
MOLECULAR PHARMACOLOGY, 2008, 73 (02) :410-418
[30]   A docking site for G protein βγ subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways [J].
Mahon, MJ ;
Bonacci, TM ;
Divieti, P ;
Smrcka, AV .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (01) :136-146